2023 Parkinson’s Update: What’s new? What’s next?
Each year in the U.S., an estimated 90,000 people are diagnosed with Parkinson’s disease, a number that is expected to grow as the population ages.
Join VAI’s Dr. Darren Moore and Dr. Laurent Roybon for an update on the latest Parkinson’s research, from groundbreaking discoveries in the lab to promising treatments under study in clinical trials. They’ll highlight the role of genetics in Parkinson’s, advances in how we study the disease (and why this is important), and how people with Parkinson’s right here in West Michigan are empowering advances.
Complimentary valet at the VAI main entrance for those attending in-person.
- 12:00 pm – 12:10 pm Welcome remarks and introduction of speakers by Emcee Maranda
- 12:10 pm – 12:40 pm Presentation by Dr. Darren Moore and Dr. Laurent Roybon
- 12:40 pm – 12:55 pm Q&A with in-person audience facilitated by Maranda
- 12:55 pm – 1:00 pm Closing remarks by Maranda
Chair and Professor, Department of Neurodegenerative Science
Director, VAI MiND Program
Dr. Darren Moore seeks new diagnostic and treatment approaches for Parkinson’s by investigating the inherited form of the disease, which comprises 5%–10% of cases. Discoveries from Moore’s lab routinely elucidate the faulty molecular interactions that transform healthy, functioning neurons into diseased ones.
Associate Professor, Department of Neurodegenerative Science
Director, iPSC Platform, MiND Program
Studying complex diseases requires equally sophisticated tools. Dr. Laurent Roybon’s team develops robust cell-based models to enable breakthroughs in Parkinson’s and other age-related neurodegenerative diseases.